Search hospitals > Hawaii > Honolulu
Cancer Research Center of Hawaii
Claim this profileHonolulu, Hawaii 96813
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Leukemia
421 reported clinical trials
17 medical researchers
Summary
Cancer Research Center of Hawaii is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Leukemia and other specialties. Cancer Research Center of Hawaii is involved with conducting 421 clinical trials across 430 conditions. There are 17 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Michael Carney, MD, and Jami A. Fukui.Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Jeffrey L. BerenbergStraub Clinic and Hospital2 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
29 reported clinical trials
77 drugs studied
Jared D. AcobaQueen's Medical Center2 years of reported clinical research
Studies Colon Cancer
Studies Pancreatic Cancer
18 reported clinical trials
38 drugs studied
Michael Carney, MDKapiolani Medical Center for Women and Children5 years of reported clinical research
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
14 reported clinical trials
29 drugs studied
Jami A. FukuiKapiolani Medical Center for Women and Children6 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
14 reported clinical trials
35 drugs studied
Clinical Trials running at Cancer Research Center of Hawaii
Lung Cancer
Breast Cancer
Cancer
Breast cancer
Ovarian Cancer
Pancreatic Cancer
Esophageal cancer
Non-Small Cell Lung Cancer
Laryngeal Cancer
Pancreatic Carcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting2 awards Phase 38 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cancer Research Center of Hawaii?
Cancer Research Center of Hawaii is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Leukemia and other specialties. Cancer Research Center of Hawaii is involved with conducting 421 clinical trials across 430 conditions. There are 17 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Michael Carney, MD, and Jami A. Fukui.
Where is Cancer Research Center of Hawaii located?
The Cancer Research Center of Hawaii is situated at the University of Hawaii Cancer Center in Honolulu, HI, on the University of Hawaii at Manoa campus. It is located near the intersection of East-West Road and University Avenue.
Who should I call to ask about financial aid or insurance network?
For cancer patients in Hawaii seeking financial assistance and insurance support, the following resources are available:
- **Hawaii Society of Clinical Oncology (HSCO) and Association of Community Cancer Centers (ACCC):** Offers a digital Patient Assistance & Reimbursement Guide with information on financial assistance programs, including direct links, phone numbers, and eligibility criteria.
- **American Cancer Society in Hawaii:** Provides free programs, services, and emotional support for managing cancer treatment and recovery. Contact at 1-800-227-2345 for patient services and information.
- **The Queen's Health System:** Offers financial resources, health insurance coverage options, and a Billing Portal on MyChart for secure online payments.
- **Hawaii Children's Cancer Foundation:** Provides financial assistance for families with a child diagnosed with cancer. Contact at 808-528-5161 for more information and eligibility requirements.
- **Hawaii Cancer Care:** Offers financial assistance for cancer patients, with details available on their website.
What insurance does Cancer Research Center of Hawaii accept?
The Cancer Center of Hawaii, part of The Queen's Medical Center, accepts various insurance plans for cancer care services. For detailed information on accepted insurance plans, contact the Cancer Center of Hawaii directly. City of Hope hospitals and Outpatient Care Centers in Hawaii accept commercial insurance, Medicare, Medicaid, and some U.S. Department of Veterans Affairs and TRICARE plans.
What awards or recognition has Cancer Research Center of Hawaii received?
The Cancer Research Center of Hawaii, located in Honolulu, has been awarded a $6 million Cancer Center Support Grant for its research efforts. It holds a national designation that aids in securing approximately $40 million yearly in grants from the National Institutes of Health. The center's Multiethnic Cohort (MEC) study, funded by the National Cancer Institute since 1993, plays a crucial role in exploring cancer disparities across various ethnic groups.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.